Cited by 5Explainable Artificial Intelligence (XAI)Pancreatic and Hepatic Oncology ResearchRadiomics and Machine Learning in Medical Imaging

Explainable artificial intelligence in pancreatic cancer prediction: from transparency to clinical decision-making

Open access
Alharbi, Wardah, Alfayez, Asma Abdullah·2025·Frontiers in Oncology

Abstract

Background/Objectives: Pancreatic cancer (PC) remains among the most lethal malignancies worldwide, with a persistently low 5-year survival rate despite advances in systemic therapies and surgical innovation. Machine learning (ML) has emerged as a transformative tool for early detection, prognostic modelling, and treatment planning in PC, yet widespread clinical use is constrained by the “black box” nature of many models. Explainable artificial intelligence (XAI) offers a pathway to reconcile model accuracy with clinical trust, enabling transparent, reproducible, and clinically meaningful predictions. Methods: We reviewed literature from 2020–2025, focusing on ML-based studies in PC that incorporated or discussed XAI techniques. Methods were grouped by model architecture, data modality, and interpretability framework. We synthesized findings to evaluate the technical underpinnings, interpretability outcomes, and clinical relevance of XAI applications. Results: Across 21 studies on ML in PC, only three studies explicitly integrated XAI, primarily using SHAP and SurvSHAP. These methods helped identify key biomarkers, comorbidities, and survival predictors, while enhancing clinician trust. XAI approaches were categorized by staging (ante-hoc vs. post-hoc ), compatibility (model-agnostic vs . model-specific), and scope (local vs . global explanations). Barriers to adoption included methodological instability, limited external validation, weak workflow integration, and lack of standardized evaluation. Conclusions: XAI has the potential to serve as a cornerstone for advancing transparent, trustworthy ML in PC prediction. By clarifying model reasoning, XAI enhances clinical interpretability and regulatory readiness. This review provides a technical and clinical synthesis of current XAI practices, positioning explainability as essential for translating ML innovations into actionable oncology tools.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fonc.2025.1720039

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Alharbi, W., & Alfayez, A. A.
Affiliations
King Saud bin Abdulaziz University for Health Sciences (SA)
Corresponding author
Alfayez, Asma Abdullah
Venue
Frontiers in Oncology
Published
2025-12-17
Volume
15
Pages
1720039-1720039
ISSN
2234-943X (ISSN-L)
OpenAlex
W4417415155
Cited by
5
References
51
Citations by year
2026: 5
FWCI
0.48
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Oncology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
King Abdullah International Medical Research Center
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › Explainable Artificial Intelligence (XAI)
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
Keywords
explainable AI, pancreatic cancer, cancer prediction, SHAP, model interpretability, clinical decision-making, clinician trust, biomarker discovery, prognostic modelling, early detection, external validation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review